SUMMERSTORM BLOODSTOCK LTD

Company Registration Number:
13415410 (England and Wales)

Unaudited abridged accounts for the year ended 31 May 2026

Period of accounts

Start date: 01 June 2025

End date: 31 May 2026

SUMMERSTORM BLOODSTOCK LTD

Contents of the Financial Statements

for the Period Ended 31 May 2026

Balance sheet
Notes

SUMMERSTORM BLOODSTOCK LTD

Balance sheet

As at 31 May 2026


Notes
2026
2025


£
£
Called up share capital not paid: 0 100
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 38,445 24,760
Investments:   0 0
Total fixed assets: 38,445 24,760
Current assets
Stocks: 0 0
Debtors:   22,180 5,650
Cash at bank and in hand: 62,784 2,525
Investments:   0 0
Total current assets: 84,964 8,175
Creditors: amounts falling due within one year:   (47,780) (17,786)
Net current assets (liabilities): 37,184 (9,611)
Total assets less current liabilities: 75,629 15,249
Creditors: amounts falling due after more than one year:   (4,482) (560)
Total net assets (liabilities): 71,147 14,689
Capital and reserves
Called up share capital: 100 100
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 71,047 14,589
Shareholders funds: 71,147 14,689

The notes form part of these financial statements

SUMMERSTORM BLOODSTOCK LTD

Balance sheet statements

For the year ending 31 May 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 15 July 2026
and signed on behalf of the board by:

Name: Stephen McCluskey
Status: Director

The notes form part of these financial statements

SUMMERSTORM BLOODSTOCK LTD

Notes to the Financial Statements

for the Period Ended 31 May 2026

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

SUMMERSTORM BLOODSTOCK LTD

Notes to the Financial Statements

for the Period Ended 31 May 2026

2. Employees

2026 2025
Average number of employees during the period 0 0

SUMMERSTORM BLOODSTOCK LTD

Notes to the Financial Statements

for the Period Ended 31 May 2026

3. Tangible Assets

Total
Cost £
At 01 June 2025 24,760
Additions 46,980
Disposals (33,295)
At 31 May 2026 38,445
Depreciation
At 01 June 2025 0
Charge for year 0
On disposals 0
Other adjustments 0
At 31 May 2026 0
Net book value
At 31 May 2026 38,445
At 31 May 2025 24,760